Peer Review History
| Original SubmissionAugust 8, 2019 |
|---|
|
PONE-D-19-22440 The Impact of Rehabilitation Frequency on the Risk of Stroke in Patients with Rheumatoid Arthritis PLOS ONE Dear Mr. Lin, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. We would appreciate receiving your revised manuscript by Nov 17 2019 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Seana Gall Academic Editor PLOS ONE Journal Requirements: We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data. 2. Please include your ethics statement and ethics approval details in the Methods section of your manuscript. 3. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data. Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: I Don't Know ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: General comments: In this case-control study, the authors use registry data aiming to investigate whether in people with rheumatoid arthritis, rehabilitation frequency is associated with lesser risk of stroke. People had higher odds of stroke if they had hypertension or diabetes and a greater number of rehabilitation sessions did not reduce the odds of stroke. Stratification by RA severity appears to reduce risk for people with moderate RA participating in more than 40 sessions of rehabilitation per year. Exercise is an important modifiable risk factor for stroke, and as such the study investigates the effect of exercise on stroke risk in a population with an underlying chronic condition. While this knowledge is important for the RA population, the manuscript could be reviewed to make a more convincing argument for the importance of this study and the study findings. At present, the language overstates the findings and could be toned down. Specific comments Materials and methods: 1. An important addition would be greater detail about the rehabilitation sessions. While this may be difficult to ascertain from the registry, the rehabilitation sessions may or may not have included the type and intensity and frequency of exercise needed to plausibly influence the odds of stroke. 2. It would be helpful to include some further justification about the definition of RA severity used for stratification based on medication types. 3. The statistically adjustment information currently in the design section (lines 114-115) would be better placed in the statistical analysis paragraph. Results: 1. In table 1, the groups are not matched for participant numbers (n=582 v n=591) can the reason for this be clarified in the text and any missing data explained. 2. Additionally, in table 1 – could the authors be more specific about the number of rehabilitation sessions. Is this the total number of sessions over the 6 years of data or a mean number of sessions with SDs? The numbers listed appear very low compared to the dose of exercise that would be required to significantly influence stroke via mechanisms such as modifying BP or diabetes status. 3. Table 2: It would be helpful for the results to reworded to clearly specify what variables are in the final adjusted model. This may be an English language issue, but it is difficult to interpret if the model includes all the variables listed from the table title and the text or if the table is presenting the variables listed. This is important for the reader to help interpret the results of the study and is not clear as written. Discussion: 1. The discussion is quite long and would benefit from revision to more concisely discuss the study findings. It’s is difficult to read in its present form. 2. The section in the discussion that justifies the method of classifying RA severity appears contradictory. I appreciate that the registry has limited data available – However, previous literature does not fully support the method used in this study. Are there further justifications for the choice of methods used in this study? 3. The finding that the moderately severe RA group were at higher risk of stroke is interesting (lines 220-230) and perhaps a more robust finding than the effect of number of rehabilitation sessions. This could be discussed and highlighted further. 4. Paragraph commencing Line 237: the authors discuss the role of exercise and physical activity and a sedentary lifestyle. However, because of the limited detail about the rehabilitation sessions we do not know what the ‘active ingredient’ of the rehabilitation program is and this significantly reduces the strength of the findings. Perhaps the choice of words would be used consistently as to whether the rehabilitation is cardiovascular exercise, or more general physical activity (unplanned, not about fitness) or sedentary time. All confer different biological effects on cardiovascular and cardiometabolic health. The discussion here is mixed and therefore is less specific than it could be. 5. The authors consistently refer to >40 rehabilitation sessions as being ‘aggressive’. This language should be toned down through the manuscript as it is not in fact a high intensity of intervention. Reviewer #2: This is an interesting paper looking at the association between rehabilitation frequency and incidence of stroke among people with rheumatoid arthritis. Some comments for the authors are as below: Major comments Design - I have a big concern regarding the study design since the control group was only matched with age, sex, time interval between RA diagnosis and stroke. The study aim was to investigate the association between rehab frequency and incidence of stroke among people with RA, it is assumed that the control group should ideally have similar age, gender, and health (e.g. comorbidities) as the case group. However, as shown in Table 2, those with stroke had higher rates of hypertension, diabetes and hyperlipidemia compared to those without stroke. Adjusting for these factors may not address the issue. - It is unclear how investigators dealt with several disadvantages of the study design including retrospective nature, appropriateness of control group and possibility of recall bias. - Please provide reference(s) for the cut-off point of 40 training sessions for intensive rehab. Methods & findings - In the legends of Table 2 and Table 3, Hazard ratios should be changed to Odds ratio since authors performed logistic regression. - Please clarify the exact logistic regression models used for the findings shown in Table 2 and Table 3. Were they bivariable or multivariable models? It seems that after accounting for age, sex, comorbidities, and RA severity, there was no evidence of a statistically significant association between rehab frequency and stroke incidence. - Please provide the reason for stratifying analyses by RA severity? Explain by checking interaction. Discussion - Some key discussions about the classification of RA severity could be moved up to the design section to support the reasons for using the dosage of medications to categorise the severity (instead of using other methods). - In the earlier section, the authors stated that this study aim was to investigate the association between rehab frequency and incidence of stroke. However, in paragraph 3 of the discussion part, a different aim was mentioned “Instead, we compared the stroke risk among different levels of RA disease severity”. Please clarify. - According to my concern above, the interpretation of findings shown in Tables 2 and 3 may need to be changed, and the relevant changes in the discussion part may be required. - Is there any other potential factor that may influence the association between rehab frequency and incidence of stroke such as type of rehabilitation and the length of treatment? Please also discuss. Minor comments - The use of different terms such as aggressive rehabilitation and intensive rehabilitation throughout the paper may be unclear to non-specialists. Please provide definitions. - STROBE Statement—Checklist of items that should be included in reports of case-control studies ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Hoang T Phan [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-19-22440R1 The Impact of Rehabilitation Frequency on the Risk of Stroke in Patients with Rheumatoid Arthritis PLOS ONE Dear Mr. Lin, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. In the response to reviewers document please provide (1) the page and line numbers for the changes that have been made and (2) a summary of the actual changes made to the text. Note that reviewer 2 has requested additional changes following the first revision. We would appreciate receiving your revised manuscript by Dec 26 2019 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Seana Gall Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: Design: 1. The authors explained that “If medical comorbidities including hypertension, diabetes and hyperlipidemia were to be matched in our study, the case number in the control group will be very few, rendering subsequent statistical analysis impossible and meaningless.” Response: Please acknowledge this study limitation in the discussion explaining why two groups were matched only for age, sex, and the time interval between RA and stroke diagnosis but not for comorbidities/other factors (e.g. lower statistical power). Methods and results: 2. The authors explained that “Our logistic regression model is multivariate in nature. The model is like an equation “y=ax1+bx2+cx3+dx4+ex5+fx6+gx7+h”. While y is stroke, x1 to x7 are age, sex, hypertension, DM, hyperlipidemia, number of rehabilitation per year, and severity of RA, respectively.” Response: Multivariable models should be mentioned in Tables 2 and 3 (in table legends or using footnotes) 3. “The reason for us to do stratified analysis by RA severity is because we cannot find significant association between rehabilitation frequency and stroke incidence in the entire cohort we located. Since more physical activities brought by more frequent rehabilitation visits had been considered to be beneficial for stroke prevention, our study result using the entire cohort seems to be unreasonable. Therefore, stratified analysis was needed to clarify the results in the subgroups patients with RA.” Response: So the stratified analysis is more likely to be an ad-hoc analysis which you had not thought about upfront. This was because significant association between rehabilitation frequency and stroke incidence in the entire cohort was observed. To facilitate the readers, I would suggest acknowledge the main findings and clarify the reason for undertaking the ad-hoc analysis and its results in the results section Discussion 3. “We agree that different types, intensity and durations of exercise incorporated in the rehabilitation sessions may influence the incidence of stroke. However, the information of detailed exercise programs mentioned above cannot be obtained in the database we used. Nevertheless, rehabilitation doctors and physical therapists in Taiwan always design exercise programs for patients according to ACSM's Guidelines for Exercise Testing and Prescription, and the comprehensive rehabilitation programs in Taiwan regularly constitute of strengthening and aerobic parts of exercise training” Response: Please also acknowledge this limitation in the discussion section. Further research to address this gap may inform the current guidelines. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: Yes: Hoang Phan [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
PONE-D-19-22440R2 The Impact of Rehabilitation Frequency on the Risk of Stroke in Patients with Rheumatoid Arthritis PLOS ONE Dear Mr. Lin, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please see below for additional revision. We would appreciate receiving your revised manuscript by Jan 19 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Seana Gall Academic Editor PLOS ONE Journal Requirements: Additional Editor Comments: Thank you for your revisions. Please amend the term 'multivariate' to 'multivariable'. The latter is the correct statistical term for this type of analysis. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 3 |
|
The Impact of Rehabilitation Frequency on the Risk of Stroke in Patients with Rheumatoid Arthritis PONE-D-19-22440R3 Dear Dr. Lin, We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements. Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication. Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. With kind regards, Seana Gall Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-19-22440R3 The Impact of Rehabilitation Frequency on the Risk of Stroke in Patients with Rheumatoid Arthritis Dear Dr. Lin: I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. For any other questions or concerns, please email plosone@plos.org. Thank you for submitting your work to PLOS ONE. With kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Seana Gall Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .